The role of cytochrome P450 and cytochrome P450 reductase in the reductive bioactivation of the novel benzotriazine di-N-oxide hypoxic cytotoxin 3-amino-l,2,4-benzotriazine-l ,4-dioxide (SR 4233, WIN 59075) by mouse liver
- 1 July 1992
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 44 (2) , 251-259
- https://doi.org/10.1016/0006-2952(92)90007-6
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Reductive metabolism of 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233) and the induction of unscheduled DNA synthesis in rat and human derived cell linesCarcinogenesis: Integrative Cancer Research, 1990
- Enzymology of the reductive bioactivation of SR 4233Biochemical Pharmacology, 1990
- Molecular enzymology of the reductive bioactivation of hypoxic cell cytotoxinsInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Structure-activity relationships for benzotriazine DI-N-oxidesInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Enhancement of radiation-induced tumor cell killing by the hypoxic cell toxin SR 4233Radiotherapy and Oncology, 1988
- Molecular mechanisms for the hypoxiadependent activation of 3-amino-1,2,4-benzotriazine-1, 4-dioxide (SR 4233)Biochemical Pharmacology, 1988
- Metabolism and reactions of quinoid anticancer agentsPharmacology & Therapeutics, 1987
- Identification of two major reduction products of the hypoxic cell toxin 3-amino-1,2,4-benzotriazine-1,4-dioxideBiochemical Pharmacology, 1986
- SR-4233: A new bioreductive agent with high selective toxicity for hypoxic mammalian cellsInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Reductive Drug MetabolismDrug Metabolism Reviews, 1983